Stony Brook University, officially the State University of New York at Stony Brook, is a public research university in Stony Brook, New York. Along with the University at Buffalo, it is one of the State University of New York system's two flagship institutions.

During the past decade, Stony Brook University conducted 107 clinical trials. In the 10-year time frame, 107 clinical trials started and 39 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 30 clinical trials were completed. i.e. 65.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stony Brook University" #1 sponsor was "Stony Brook University" with 45 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 35 trials sponsored, "Gynecologic Oncology Group" with 34 trials sponsored, "Children's Oncology Group" with 19 trials sponsored and "Pfizer" with 19 trials sponsored. Other sponsors include 129 different institutions and companies that sponsored additional 101 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stony Brook University" #1 collaborator was "National Cancer Institute (NCI)" with 53 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 16 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 9 trials as a collaborator, "Stony Brook University" with 7 trials as a collaborator and "Bristol-Myers Squibb" with 5 trials as a collaborator. Other collaborators include 188 different institutions and companies that were collaborators in the rest 155 trials.

According to Clinical.Site data, the most researched conditions in "Stony Brook University" are "HIV Infections" (43 trials), "Ovarian Cancer" (17 trials), "Multiple Sclerosis" (13 trials), "Primary Peritoneal Cavity Cancer" (12 trials) and "Endometrial Cancer" (10 trials). Many other conditions were trialed in "Stony Brook University" in a lesser frequency.

Most popular intervention types in "Stony Brook University" are "Drug" (177 trials), "Biological" (28 trials), "Device" (25 trials), "Procedure" (25 trials) and "Behavioral" (23 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "cisplatin" (16 trials), "etoposide" (14 trials), "Zidovudine" (13 trials) and "cyclophosphamide" (11 trials). Other intervention names were less common.

The vast majority of trials in "Stony Brook University" are 228 trials for "All" genders, 44 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Stony Brook University". undefined are not yet recruiting, 21 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 168 completed trials in Stony Brook University, 1 suspended trials, and 40 terminated clinical trials to date.

Out of the total trials that were conducted in Stony Brook University, 29 "Phase 1" clinical trials were conducted, 84 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 61 trials that are defined as “Not Applicable".